Published in Malar J on July 19, 2016
Developmental pharmacology--drug disposition, action, and therapy in infants and children. N Engl J Med (2003) 7.51
The public health impact of chloroquine resistance in Africa. Am J Trop Med Hyg (2001) 5.22
Chloroquine-resistant malaria. J Infect Dis (2001) 4.58
Chloroquine resistance in Plasmodium vivax. Antimicrob Agents Chemother (2004) 4.54
Diagnosis of resistance to chloroquine by Plasmodium vivax: timing of recurrence and whole blood chloroquine levels. Am J Trop Med Hyg (1997) 3.61
Antimalarial dosing regimens and drug resistance. Trends Parasitol (2008) 2.40
Clearance of drug-resistant parasites as a model for protective immunity in Plasmodium falciparum malaria. Am J Trop Med Hyg (2003) 2.29
Vivax malaria resistant to treatment and prophylaxis with chloroquine. Lancet (1993) 2.23
Chloroquine-resistant Plasmodium vivax malaria in Peru. Am J Trop Med Hyg (2003) 2.12
Chloroquine-resistant Plasmodium vivax malaria in Debre Zeit, Ethiopia. Malar J (2008) 1.91
Body water compartments in children: changes during growth and related changes in body composition. Pediatrics (1961) 1.80
Simplified antimalarial therapeutic monitoring: using the day-7 drug level? Trends Parasitol (2008) 1.70
Clinical pharmacokinetics and metabolism of chloroquine. Focus on recent advancements. Clin Pharmacokinet (1996) 1.42
Chloroquine-resistant Plasmodium vivax malaria in Serbo town, Jimma zone, south-west Ethiopia. Malar J (2009) 1.33
Therapeutic efficacy of chloroquine and chloroquine plus primaquine for the treatment of Plasmodium vivax in Ethiopia. Acta Trop (2009) 1.20
Chloroquine for treatment of acute attacks of vivax malaria. J Am Med Assoc (1946) 1.20
Drug metabolism and disposition in children. Fundam Clin Pharmacol (2003) 1.20
Potential contribution of prescription practices to the emergence and spread of chloroquine resistance in south-west Nigeria: caution in the use of artemisinin combination therapy. Malar J (2009) 1.10
Different doses of amodiaquine and chloroquine for treatment of uncomplicated malaria in children in Guinea-Bissau: implications for future treatment recommendations. Trans R Soc Trop Med Hyg (2006) 1.08
Pharmacokinetics, pharmacodynamics, and allometric scaling of chloroquine in a murine malaria model. Antimicrob Agents Chemother (2011) 1.06
Chloroquine is grossly overdosed and overused but well tolerated in Guinea-bissau. Antimicrob Agents Chemother (2008) 1.06
Population pharmacokinetics of chloroquine and sulfadoxine and treatment response in children with malaria: suggestions for an improved dose regimen. Br J Clin Pharmacol (2008) 1.04
Efficacy and safety of chloroquine for treatment in patients with uncomplicated Plasmodium vivax infections in endemic countries. Trans R Soc Trop Med Hyg (2010) 1.02
Impact of developmental pharmacology on pediatric study design: overcoming the challenges. J Allergy Clin Immunol (2000) 0.98
Malaria parasites and chloroquine concentrations in Tanzanian schoolchildren. Trop Med Parasitol (1994) 0.96
Chemoresistance of P. falciparum in urban areas of Yaounde, Cameroon. Part 1: Surveillance of in vitro and in vivo resistance of Plasmodium falciparum to chloroquine from 1994 to 1999 in Yaounde, Cameroon. Trop Med Int Health (2000) 0.95
Resistance to antimalarial drugs: molecular, pharmacologic, and clinical considerations. Pediatr Res (2009) 0.94
Evaluation of five formulae for estimating body surface area of nigerian children. Ann Med Health Sci Res (2014) 0.90
Resistance of infection by Plasmodium vivax to chloroquine in Bolivia. Malar J (2015) 0.89
Concentrations of chloroquine and malaria parasites in blood in Nigerian children. Antimicrob Agents Chemother (2000) 0.85
Chloroquine is grossly under dosed in young children with malaria: implications for drug resistance. PLoS One (2014) 0.81
Slow clearance of Plasmodium vivax with chloroquine amongst children younger than six months of age in the Brazilian Amazon. Mem Inst Oswaldo Cruz (2014) 0.80